Hydronidone not checked

Beijing Continent Pharmaceutical Co, Ltd. · F351

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
13 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“After randomization, the experimental group received hydronidone capsules three times a day, 3 capsules each time, for 5 years.”In the company’s words, NCT05905172 on ClinicalTrials.gov
Tested for
Liver Fibrosis (2 trials), Liver Fibrosis in Chronic Hepatitis B, Renal Insufficiency Chronic
Main trialPhase 3
“This study is a Phase IIIb extension trial following the "A Randomized, Double-blind, Placebo-controlled, Multicenter, Entecavir-based, Phase III Clinical Trial of Hydronidone Capsule in the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B". The main objective of this study is to evaluate the effectiveness and the safety of hydronidone capsules for long-term treatment of patients with chronic viral hepatitis B liver fibrosis.”In the company’s words, NCT05905172 on ClinicalTrials.gov
Other names
F351

Other drugs for Liver Fibrosis

All 19 drugs for Liver Fibrosis

Coming up3

Changes1

Last 90 days

Trials13

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 20 Jun 2028 Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Phase 3Recruiting 30 Dec 2028 A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
Phase 1Recruiting 1 Dec 2026 A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Phase 3Completed 22 Oct 2024 Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
Phase 3Completed 28 Jul 2026 A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Phase 2Completed 22 Jun 2026 A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
Phase 2Completed 27 Jul 2026 A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
Phase 1Completed 27 Nov 2019 Study on Pharmacokinetics of Hydronidone
Phase 1Completed 9 Oct 2020 Study on PK of Hydronidone in Patients and Special Population
Phase 1Completed 9 Feb 2026 QTc Assessment in a Single-Dose Study of Hydronidone Capsules
Phase 1Completed 6 May 2026 [¹⁴C] Hydronidone Mass Balance Study
Phase 1Completed 11 May 2026 Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
Phase 1Completed 28 May 2026 The Phase Ⅰd Clinical Trial of Hydronidone Capsules
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Hydronidone

Following is part of Solo: you see every change to Hydronidone the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in